Search research articles
Contact Us
Filters
Showing results (181-190 of 211) with videos related to
Page
of 22
Sort By:
Urologic Oncology
|
February 15, 2020
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology
|
August 9, 2021
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology
|
June 9, 2018
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy
N Vasdev, H Zargar, J P Noël, et al.
Urologic Oncology
|
November 3, 2019
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy
Anna J Black, Homayoun Zargar, Kamran Zargar-Shoshtari, et al.
World Journal of Urology
|
September 28, 2022
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
Sarah M H Einerhand, Anna J Black, Homayoun Zargar, et al.
Actas Urologicas Espanolas
|
March 18, 2026
Impact of Intravesical BCG Therapy on Quality of Life in Non-Muscle-Invasive Bladder Cancer: A Prospective Evaluation Using The FACT-Bl Questionnaire
J Caño-Velasco, A Luis-Cardo, J C Moreno-Cortés, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 13, 2019
Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation
Judith Wienke, Felicitas Bellutti Enders, Johan Lim, et al.
BJU International
|
March 3, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups
Ana Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina, et al.
European Urology
|
September 27, 2014
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer
Homayoun Zargar, Patrick N Espiritu, Adrian S Fairey, et al.
World Journal of Urology
|
October 28, 2025
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study
Mario de Angelis, Francesco Pellegrino, Pietro Scilipoti, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 211) with videos related to
Sort By:
Page
of 22
Urologic Oncology
|
February 15, 2020
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology
|
August 9, 2021
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology
|
June 9, 2018
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy
N Vasdev, H Zargar, J P Noël, et al.
Urologic Oncology
|
November 3, 2019
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy
Anna J Black, Homayoun Zargar, Kamran Zargar-Shoshtari, et al.
World Journal of Urology
|
September 28, 2022
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
Sarah M H Einerhand, Anna J Black, Homayoun Zargar, et al.
Actas Urologicas Espanolas
|
March 18, 2026
Impact of Intravesical BCG Therapy on Quality of Life in Non-Muscle-Invasive Bladder Cancer: A Prospective Evaluation Using The FACT-Bl Questionnaire
J Caño-Velasco, A Luis-Cardo, J C Moreno-Cortés, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 13, 2019
Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation
Judith Wienke, Felicitas Bellutti Enders, Johan Lim, et al.
BJU International
|
March 3, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups
Ana Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina, et al.
European Urology
|
September 27, 2014
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer
Homayoun Zargar, Patrick N Espiritu, Adrian S Fairey, et al.
World Journal of Urology
|
October 28, 2025
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study
Mario de Angelis, Francesco Pellegrino, Pietro Scilipoti, et al.
Page
of 22